Cite
HARVARD Citation
Shah, J. et al. (2023). Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B. Current medical research and opinion. pp. 227-237. [Online].